New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
10:04 EDTTRV, SPN, MOS, GSK, CAE, INTC, TW, QSII, LOGM, DLTR, ESV, VZ, TRGP, ORCL, HOLX, CBL, HEROOn the Fly: Analyst Downgrade Summary
CAE (CAE) downgraded to Hold from Buy at Canaccord... CBL & Associates (CBL) downgraded to Market Perform from Outperform at Cowen... Dollar Tree (DLTR) downgraded to Neutral from Buy at Sterne Agee... GlaxoSmithKline (GSK) downgraded to Market Perform from Outperform at Cowen... Hologic (HOLX) downgraded to Buy from Strong Buy at ISI Group... LogMeln (LOGM) downgraded to Market Perform from Outperform at Cowen... Mosaic (MOS) downgraded to Sell from Neutral at Goldman... Oracle (ORCL) downgraded to Perform from Outperform at Oppenheimer... Quality Systems (QSII) downgraded to Cautious from Neutral at ISI Group... Superior Energy (SPN) downgraded to Market Perform from Outperform at Wells Fargo... Targa Resources (TRGP) downgraded to Hold from Buy at Jefferies... Towers Watson (TW) downgraded to Neutral from Buy at Citigroup... Travelers (TRV) downgraded to Outperform from Top Pick at RBC Capital... Verizon (VZ) downgraded to Sector Perform from Outperform at Pacific Crest... Intel (INTC) downgraded to Hold from Buy at Drexel Hamilton... Hercules Offshore (HERO) downgraded to Accumulate from Buy at Tudor Pickering... Ensco (ESV) downgraded to Hold from Buy at Tudor Pickering.
News For CAE;CBL;DLTR;GSK;HOLX;LOGM;MOS;ORCL;QSII;SPN;TRGP;TW;TRV;VZ;INTC;HERO;ESV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 21, 2015
10:37 EDTINTCAnalysts upbeat on HP ahead of split after earnings beat
Subscribe for More Information
08:54 EDTINTCIntel price target lowered to $25 from $32 at Baird
Subscribe for More Information
05:25 EDTGSKNovartis acquires all remaining rights to Ofatumumab from GSK
Novartis (NVS) announced that it has entered into an agreement to acquire all remaining rights to Ofatumumab from GlaxoSmithKline (GSK). Ofatumumab, a fully human monoclonal antibody which targets CD20, is being developed for relapsing remitting multiple sclerosis, or RRMS, and other autoimmune indications. Novartis previously acquired the rights to Ofatumumab for oncology indications and it is marketed under the brand name Arzerra. Novartis will be responsible for the worldwide development, regulatory and commercialization activities for Ofatumumab. Under the terms of the agreement, Novartis will make an initial upfront payment of $300M to GSK for the acquisition of the compound and a further payment of $200M payable following the start of a phase III study in MS by Novartis. Upon completion of pre-determined milestones, contingent payments of up to $534M may be made. Novartis will also pay royalties of up to 12% to GSK on any future net sales of Ofatumumab in autoimmune conditions.
August 20, 2015
16:00 EDTINTCOptions Update; August 20, 2015
iPath S&P 500 VIX Short-Term Futures up 1.49 to 17.70. Option volume leaders: AAPL BAC FB NFLX DIS INTC BABA MU
14:39 EDTINTCEarnings Watch: Hewlett-Packard reports ahead of company split
Subscribe for More Information
11:49 EDTORCLOptions with increasing implied volatility
Options with increasing implied volatility: SRPT ACHN VIAV ZG RAD DIS ORCL SPY XLF OEX
10:00 EDTTRGPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:32 EDTORCLOracle agrees to acquire Maxymiser
Subscribe for More Information
08:19 EDTTRGPJefferies sees downside risk in Targa, cuts to Underperform
Subscribe for More Information
08:02 EDTVZFCC to hold a conference and workshop
2015 Supplier Diversity Conference & Workshop is being held at FCC Washington, D.C. offices on August 20 at 9:30 am. Webcast Link
05:58 EDTTRGPTarga Resources downgraded to Underperform from Hold at Jefferies
Subscribe for More Information
August 19, 2015
10:20 EDTVZBig telecom firms put M&A on hold, CTFN reports
Subscribe for More Information
08:22 EDTVZSprint traffic levels increasing, says Pacific Crest
Subscribe for More Information
06:14 EDTINTCIntel to launch contest show on Turner Broadcasting, WSJ reports
Intel (INTC) is making a foray into reality television by developing a contest show with Mark Burnett and Time Warner's (TWX) Turner Broadcasting unit, the Wall Street Journal reports. The program will be called "America's Greatest Makers" and will engage "do-it-yourselfers" who turn microchips and other components into devices and gadgets, competing for a $1M prize, the report says. The show is scheduled to appear on TV and other media channels in 2016, the report adds. Reference Link
August 18, 2015
18:30 EDTINTCChip makers advance after Analog Devices reports Q3 financial results
Subscribe for More Information
13:35 EDTINTCMicrochip selects Intel technology to enhance Internet-of-Things security
Subscribe for More Information
13:32 EDTINTCAtmel collaborates with Intel on Internet of Things applications
Subscribe for More Information
11:34 EDTVZSprint rises on plans to abandon two-year contracts
Sprint shares are higher this morning after the company's chief executive officer said that the carrier plans to move away from two-year contracts. WHAT'S NEW: In an interview with The Wall Street Journal, Sprint CEO Marcelo Claure said that the company will stop offering two-year contracts by the end of 2015 in favor of a "smartphone lease" model. Sprint began offering a lease option last year, The Journal noted, and Claure said the carrier is planning to move entirely to that model by the end of the year. As part of its shift, Sprint yesterday unveiled iPhone Forever, a new leasing plan that starts at $22 per month for an iPhone. WHAT'S NOTABLE: In a similar move earlier this month, Sprint rival Verizon (VZ) said it would drop phone subsidies and two-year contracts for new customers. T-Mobile (TMUS), another market rival, abandoned contracts over two years ago, leaving AT&T (T) as the only major U.S. carrier still offering to subsidize new smartphone purchases. Separately, Softbank (SFTBF), Sprint's primary stakeholder, disclosed last week that it increased its holdings in the company to approximately 80%, though the company said it does not plan for its stake in the carrier to exceed 85%. Meanwhile, a study released Tuesday by RootMetrics, an independent company that evaluates wireless networks, shows that Sprint is improving its network, having solidified third place nationally in overall performance, surpassing T-Mobile for the second consecutive six-month stretch. PRICE ACTION: Sprint is up 7c, or 1.52%, to $4.67 in morning trading.
August 17, 2015
07:39 EDTVZTMC to hold a conference
Subscribe for More Information
05:34 EDTQSIIQuality Systems Chief Technology Officer Steve Puckett resigns
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use